Pub. Date : 2014
PMID : 24711706
| 1 Functional Relationships(s)Download | Sentence | Compound Name | Protein Name | Organism | 
| 1 | Lapatinib, a small-molecule dual inhibitor (TKI) of both HER2 and EGFR (epidermal growth factor receptor) pathways, has an antitumor activity translated into progression-free survival benefit in HER2-positive metastatic patients previously treated with a taxane, an anthracycline, and trastuzumab. | taxane | epidermal growth factor receptor | Homo sapiens |